288 related articles for article (PubMed ID: 12429309)
1. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.
Raaijmakers R; Kirkels WJ; Roobol MJ; Wildhagen MF; Schrder FH
Urology; 2002 Nov; 60(5):826-30. PubMed ID: 12429309
[TBL] [Abstract][Full Text] [Related]
2. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.
Rietbergen JB; Kruger AE; Kranse R; Schröder FH
Urology; 1997 Jun; 49(6):875-80. PubMed ID: 9187694
[TBL] [Abstract][Full Text] [Related]
3. Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression.
Wammack R; Djavan B; Remzi M; Susani M; Marberger M
Urology; 2001 Dec; 58(6):1004-7. PubMed ID: 11744477
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
5. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
6. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
[TBL] [Abstract][Full Text] [Related]
7. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer.
Lee SH; Chen SM; Ho CR; Chang PL; Chen CL; Tsui KH
Chang Gung Med J; 2009; 32(6):623-7. PubMed ID: 20035641
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate.
de la Taille A; Antiphon P; Salomon L; Cherfan M; Porcher R; Hoznek A; Saint F; Vordos D; Cicco A; Yiou R; Zafrani ES; Chopin D; Abbou CC
Urology; 2003 Jun; 61(6):1181-6. PubMed ID: 12809894
[TBL] [Abstract][Full Text] [Related]
10. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients.
Peyromaure M; Ravery V; Messas A; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
J Urol; 2002 Jan; 167(1):218-21. PubMed ID: 11743309
[TBL] [Abstract][Full Text] [Related]
11. Complications and risk factors in transrectal ultrasound-guided prostate biopsies.
de Jesus CM; Corrêa LA; Padovani CR
Sao Paulo Med J; 2006 Jul; 124(4):198-202. PubMed ID: 17086300
[TBL] [Abstract][Full Text] [Related]
12. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases.
Enlund AL; Varenhorst E
Br J Urol; 1997 May; 79(5):777-80. PubMed ID: 9158518
[TBL] [Abstract][Full Text] [Related]
13. In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications?
Meier-Schroers M; Homsi R; Kukuk G; Wolter K; Decker G; Fischer S; Marx C; Schmeel FC; Block W; Sprinkart AM; Traeber F; Schild HH; Willinek W
Eur J Radiol; 2016 Dec; 85(12):2169-2173. PubMed ID: 27842662
[TBL] [Abstract][Full Text] [Related]
14. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
[TBL] [Abstract][Full Text] [Related]
15. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?
Puig J; Darnell A; Bermúdez P; Malet A; Serrate G; Baré M; Prats J
Eur Radiol; 2006 Apr; 16(4):939-43. PubMed ID: 16391904
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and discomfort of ten-core biopsy of the prostate evaluated by questionnaire.
Manseck A; Guhr K; Froehner M; Hakenberg OW; Wirth MP
Urol Int; 2001; 66(4):197-200. PubMed ID: 11385305
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
Lee JK; Lee S; Hong SK; Byun SS; Lee SE
BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
[TBL] [Abstract][Full Text] [Related]
18. [Adverse effects of transrectal prostatic biopsy. Analysis of 303 procedures].
Luján Galán M; Páez Bordá A; Fernández González I; Romero Cajigal I; Gómez de Vicente JM; Berenguer Sánchez A
Actas Urol Esp; 2001 Jan; 25(1):46-9. PubMed ID: 11284367
[TBL] [Abstract][Full Text] [Related]
19. Emergency attendances and hospitalisations for complications after transrectal ultrasound-guided prostate biopsies: a five-year retrospective multicentre study.
Cheng KC; Lam WC; Chan HC; Ngo CC; Cheung MH; So HS; Lam KM
Hong Kong Med J; 2019 Oct; 25(5):349-355. PubMed ID: 31601774
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates.
Salomon G; Prues S; Saul J; Budäus L; Tilki D; Schneider M; Haferkamp A; Graefen M; Boehm K
Eur Urol Focus; 2019 Nov; 5(6):992-997. PubMed ID: 29941389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
